Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Patrick F Fogarty, MD

Patrick F Fogarty, MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology/Oncology
Penn Blood Disorders Center
3rd Floor Dulles Building
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-6555
Fax: 215-615-6599
Education:
B.A.
University of Pennsylvania, 1992.
M.D. (Medicine)
Jefferson Medical College, 1996.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Van Laar ES, Warren C, Desai J, Fogarty PF: Knowledge Gaps in the Management of Hemophilia among Hematologists/Oncologists. Program and abstracts of the American Society of Hematology 54th Annual Meeting (San Francisco, CA). Poster Presentation, Abstract 4831. December 2014.

Li, R., Panckeri, K., Fogarty, P.F., Diamond, S.L.: Recombinant factor VIIa enhances platelet deposition from flowing hemophilic blood but requires the contact pathway to promote fibrin deposition. Haemophilia October 2014 Notes: Pre-published on-line http://onlinelibrary.wiley.com/doi/10.1111/hae.12558/pdf.

Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL: Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. Biomedical Engineering Society Annual Meeting. San Antonio, TX. Poster Presentation. October 2014.

Schafer, K., Munn J., Thukral, N., Tom, A., Potts, J., Krishnan, S., Brennan, A., Pierce, G.F., McAlister, S., Shapiro, A.D., Fogarty, P.F., Quon, D.V.: Dosing Routines and Bleeding Rates Before and Following Treatment With rFVIIIFc in the A-LONG Clinical Study. Haemophilia (National Hemophilia Foundation Annual Meeting, Washington, D.C. Poster Presentation) September 2014.

Van Laar ES, Warren C, Desai J , Frick N, Fogarty PF: Global Assessment of Knowledge and Practices in the Diagnosis, Classification, and Management of Hemophilia among Pediatric Providers. Haemophilia; National Hemophilia Foundation 66th Annual Meeting (Washington, DC). Poster Presentation. Abstract 0029 September 2014.

Fogarty, Patrick.: "Maintaining a Good Relationship with Your Hemophilia Treatment Center" (Patient Education Video, Department of Continuing Medical Education, Keck School of Medicine at the University of Southern California). YouTube May 2014.

Fogarty PF, Powell J, Kruse-Jarres R, Lin J, Mahlangu J, Perry D, McRae S, Potts J, Li S, Brennan A, Pierce G: Analysis of baseline characteristics and 5-day dosing interval with rFVIIIFc in the phase 3 A-LONG study. 2014 Symposium of the Thrombosis & Hemostasis Summit of North America (THSNA), Chicago, IL. Poster presentation. April 2014.

Colace, T., Fogarty, P. F., Panckeri, K. A., Li, R., Diamond, S. L.: Microfluidic assay of hemophilic blood clotting: Distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost 12: 147-58, February 2014.

PF Fogarty, T Minichiello: Disorders of Hemostasis, Thrombosis, & Antithrombotic Therapy. Current Medical Diagnosis and Treatment, 53rd Edition. SJ McPhee, MA Papadakis (eds.). McGraw Hill, Page: pp 520-546, 2014.

Shapiro, A. D., Ragni, M. V., Kulkarni, R., Oldenberg, J., Srivastava, A., Quon, D. V., Pasi, K. J., Hanabusa, H., Pabinger, I., Mahlangu, J., Fogarty, P., Lillicrap, D., Kulke, S., Potts, J., Neelakantan, S., Nestorov, I., Li, S., Dumont, J. A., Jiang, H., Brennan, A., Pierce, G. F.: Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels. J Thromb Haemost 2014.

back to top
Last updated: 10/17/2014
The Trustees of the University of Pennsylvania